Predictors of Response to Fenofibrate
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to University of Minnesota
Related studies linked through entity extraction aliases.
Diabetes and Periodontal Therapy Trial
- Status
- COMPLETED
- Phase
- PHASE3
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Exercise on Preventing PostPartum Depression
- Status
- COMPLETED
- Phase
- PHASE2
Gastrointestinal Toleration of Inulin Products
- Status
- COMPLETED
- Phase
- NA
Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers
- Status
- COMPLETED
- Phase
- NA
Treatment of Cocaine Dependence With Lisdexamfetamine
- Status
- COMPLETED
- Phase
- PHASE2
Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
- Status
- TERMINATED
- Phase
- PHASE3
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
- Status
- COMPLETED
- Phase
- PHASE2
Varenicline and Bupropion for Smoking Cessation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Metabolic Syndrome in Childhood Cancer Survivors
- Status
- COMPLETED
- Phase
- N/A
Green Tea and Reduction of Breast Cancer Risk
- Status
- COMPLETED
- Phase
- PHASE2
Repetitive Transcranial Magnetic Stimulation (rTMS) to Promote Hand Recovery in Stroke
- Status
- COMPLETED
- Phase
- PHASE1
HIV and Kidney Function Study
- Status
- COMPLETED
- Phase
- N/A
Personalized Physician Learning to Improve Hypertension Care
- Status
- COMPLETED
- Phase
- NA
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
- Status
- COMPLETED
- Phase
- N/A
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
- Status
- COMPLETED
- Phase
- PHASE3
Satiety Response After Mixed Fiber Doses
- Status
- COMPLETED
- Phase
- NA
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
- Status
- COMPLETED
- Phase
- PHASE2
Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD)
- Status
- COMPLETED
- Phase
- PHASE3